Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease

Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson’s Disease

(2022) Lucy L. Gibson et al.   Journal of Parkinsons Disease

Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters

(2022) Tommaso Schirinzi et al.   Frontiers in Neurology

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

(2022) Lucia Batzu et al.   npj Parkinsons Disease

Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson's disease: An 8-year longitudinal study

(2021) Rong Ye et al.   PARKINSONISM & RELATED DISORDERS

Neurocognitive and psychiatric disorders‐related axonal degeneration in Parkinson's disease

(2020) Christina Andica et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Confounding effect of blood volume and body mass index on blood neurofilament light chain levels

(2020) Ali Manouchehrinia et al.   Annals of Clinical and Translational Neurology

Association of serum biomarker neurofilament light concentration with post-stroke depression: A preliminary study

(2020) Hongling Zhao et al.   GENERAL HOSPITAL PSYCHIATRY

Exosomal neurofilament light

(2020) Vivian A. Guedes et al.   NEUROLOGY

Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease

(2020) Frederic Sampedro et al.   PARKINSONISM & RELATED DISORDERS

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression

(2020) Brit Mollenhauer et al.   MOVEMENT DISORDERS

Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism

(2019) Radu Constantinescu et al.   ACTA NEUROLOGICA SCANDINAVICA

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

(2019) Claire Bridel et al.   JAMA Neurology

The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study

(2019) K. Ray Chaudhuri et al.   MOVEMENT DISORDERS

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients

(2018) Tommaso Schirinzi et al.   PARKINSONISM & RELATED DISORDERS

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

(2018) Yung-Shuan Lin et al.   Scientific Reports

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort

(2017) Tanya Simuni et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study

(2017) Anette Schrag et al.   LANCET NEUROLOGY

Non-motor features of Parkinson disease

(2017) Anthony H.V. Schapira et al.   NATURE REVIEWS NEUROSCIENCE

Non motor subtypes and Parkinson's disease

(2016) Anna Sauerbier et al.   PARKINSONISM & RELATED DISORDERS

Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease

(2011) David A. Gallagher et al.   MOVEMENT DISORDERS

Is there a CSF biomarker profile related to depression in elderly women?

(2010) Pia Gudmundsson et al.   PSYCHIATRY RESEARCH

Quantitation of non-motor symptoms in Parkinson’s disease

(2008) K. Ray Chaudhuri et al.   EUROPEAN JOURNAL OF NEUROLOGY